These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Neurodegeneration: paying it off with sleep. Keene AC; Joiner WJ Curr Biol; 2015 Mar; 25(6):R234-R236. PubMed ID: 25784043 [TBL] [Abstract][Full Text] [Related]
24. Circadian clock disruption in neurodegenerative diseases: cause and effect? Musiek ES Front Pharmacol; 2015; 6():29. PubMed ID: 25774133 [TBL] [Abstract][Full Text] [Related]
25. The kynurenine pathway and neurodegenerative disease. Maddison DC; Giorgini F Semin Cell Dev Biol; 2015 Apr; 40():134-41. PubMed ID: 25773161 [TBL] [Abstract][Full Text] [Related]
26. A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial. Ngandu T; Lehtisalo J; Solomon A; Levälahti E; Ahtiluoto S; Antikainen R; Bäckman L; Hänninen T; Jula A; Laatikainen T; Lindström J; Mangialasche F; Paajanen T; Pajala S; Peltonen M; Rauramaa R; Stigsdotter-Neely A; Strandberg T; Tuomilehto J; Soininen H; Kivipelto M Lancet; 2015 Jun; 385(9984):2255-63. PubMed ID: 25771249 [TBL] [Abstract][Full Text] [Related]
27. A heme oxygenase-1 transducer model of degenerative and developmental brain disorders. Schipper HM; Song W Int J Mol Sci; 2015 Mar; 16(3):5400-19. PubMed ID: 25761244 [TBL] [Abstract][Full Text] [Related]
28. Cholinesterase inhibitors for rarer dementias associated with neurological conditions. Li Y; Hai S; Zhou Y; Dong BR Cochrane Database Syst Rev; 2015 Mar; 2015(3):CD009444. PubMed ID: 25734590 [TBL] [Abstract][Full Text] [Related]
29. Lutein protects dopaminergic neurons against MPTP-induced apoptotic death and motor dysfunction by ameliorating mitochondrial disruption and oxidative stress. Nataraj J; Manivasagam T; Thenmozhi AJ; Essa MM Nutr Neurosci; 2016 Jul; 19(6):237-46. PubMed ID: 25730317 [TBL] [Abstract][Full Text] [Related]
30. Neurodegenerative diseases and therapeutic strategies using iron chelators. Ward RJ; Dexter DT; Crichton RR J Trace Elem Med Biol; 2015; 31():267-73. PubMed ID: 25716300 [TBL] [Abstract][Full Text] [Related]
31. Fyn inhibition rescues established memory and synapse loss in Alzheimer mice. Kaufman AC; Salazar SV; Haas LT; Yang J; Kostylev MA; Jeng AT; Robinson SA; Gunther EC; van Dyck CH; Nygaard HB; Strittmatter SM Ann Neurol; 2015 Jun; 77(6):953-71. PubMed ID: 25707991 [TBL] [Abstract][Full Text] [Related]
32. A reduced astrocyte response to β-amyloid plaques in the ageing brain associates with cognitive impairment. Mathur R; Ince PG; Minett T; Garwood CJ; Shaw PJ; Matthews FE; Brayne C; Simpson JE; Wharton SB; PLoS One; 2015; 10(2):e0118463. PubMed ID: 25707004 [TBL] [Abstract][Full Text] [Related]
33. A multiancestral genome-wide exome array study of Alzheimer disease, frontotemporal dementia, and progressive supranuclear palsy. Chen JA; Wang Q; Davis-Turak J; Li Y; Karydas AM; Hsu SC; Sears RL; Chatzopoulou D; Huang AY; Wojta KJ; Klein E; Lee J; Beekly DL; Boxer A; Faber KM; Haase CM; Miller J; Poon WW; Rosen A; Rosen H; Sapozhnikova A; Shapira J; Varpetian A; Foroud TM; Levenson RW; Levey AI; Kukull WA; Mendez MF; Ringman J; Chui H; Cotman C; DeCarli C; Miller BL; Geschwind DH; Coppola G JAMA Neurol; 2015 Apr; 72(4):414-22. PubMed ID: 25706306 [TBL] [Abstract][Full Text] [Related]
34. Could astrocytes be the primary target of an offending agent causing the primary degenerative diseases of the human central nervous system? A hypothesis. Sica RE Med Hypotheses; 2015 May; 84(5):481-9. PubMed ID: 25697116 [TBL] [Abstract][Full Text] [Related]
35. Conserved epigenomic signals in mice and humans reveal immune basis of Alzheimer's disease. Gjoneska E; Pfenning AR; Mathys H; Quon G; Kundaje A; Tsai LH; Kellis M Nature; 2015 Feb; 518(7539):365-9. PubMed ID: 25693568 [TBL] [Abstract][Full Text] [Related]
36. Pharmacological management of chronic low back pain in older patients: a randomized controlled trial of the effect of pregabalin and opioid administration. Sakai Y; Ito K; Hida T; Ito S; Harada A Eur Spine J; 2015 Jun; 24(6):1309-17. PubMed ID: 25682273 [TBL] [Abstract][Full Text] [Related]
37. Trends in Atypical Antipsychotics Prescribed to Children Six Years of Age or Less on Medicaid in Kentucky. Lohr WD; Chowning RT; Stevenson MD; Williams PG J Child Adolesc Psychopharmacol; 2015 Jun; 25(5):440-3. PubMed ID: 25897616 [TBL] [Abstract][Full Text] [Related]
38. Changes in the Temperament and Character Inventory dimensions after paroxetine treatment in patients with major depressive disorder. Tomita T; Kaneda A; Nakagami T; Kaneko S; Yasui-Furukori N Hum Psychopharmacol; 2015 Sep; 30(5):334-40. PubMed ID: 25845342 [TBL] [Abstract][Full Text] [Related]